285 related articles for article (PubMed ID: 29727352)
21. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
22. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
[TBL] [Abstract][Full Text] [Related]
23. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
[TBL] [Abstract][Full Text] [Related]
24. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
Ziebarth AJ; Smith H; Killian ME; Nguyen NA; Durst JK; Subramaniam A; Kim KH; Leath CA; Straughn JM; Alvarez RD
Gynecol Oncol; 2012 Jul; 126(1):69-72. PubMed ID: 22484400
[TBL] [Abstract][Full Text] [Related]
25. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
Behtash N; Karimi Zarchi M; Deldar M
Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
[TBL] [Abstract][Full Text] [Related]
26. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
Lacorre A; Merlot B; Garabedian C; Narducci F; Chereau E; Resbeut M; Minsat M; Leblanc E; Houvenaeghel G; Lambaudie E
Eur J Surg Oncol; 2016 Mar; 42(3):376-82. PubMed ID: 26725307
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
Hanprasertpong J; Jiamset I; Atjimakul T
Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
[TBL] [Abstract][Full Text] [Related]
28. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
30. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
Fan X; Wang Y; Yang N; Zhu P
World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912
[TBL] [Abstract][Full Text] [Related]
31. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
33. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
Pieterse QD; Kenter GG; Gaarenstroom KN; Peters AA; Willems SM; Fleuren GJ; Trimbos JB
Eur J Surg Oncol; 2007 Mar; 33(2):216-21. PubMed ID: 17097845
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
35. Less extensive surgery for patients with FIGO stage IA2 cervical cancer: A population-based study.
Du Y; Xu Y
J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102291. PubMed ID: 34915167
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors influencing pelvic, extra-pelvic, and intraperitoneal recurrences in lymph node-negative early-stage cervical cancer patients following radical hysterectomy.
Kong TW; Son JH; Paek J; Chang SJ; Ryu HS
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():94-99. PubMed ID: 32590168
[TBL] [Abstract][Full Text] [Related]
37. Early cervical cancer and parametrial involvement: is it significant?
Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
[TBL] [Abstract][Full Text] [Related]
38. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F
Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352
[TBL] [Abstract][Full Text] [Related]
39. Surgical pathologic factors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival.
Piura B; Rabinovich A; Friger M
Eur J Gynaecol Oncol; 2006; 27(6):573-8. PubMed ID: 17290585
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]